Pipasha Biswas

760 total citations
15 papers, 528 citations indexed

About

Pipasha Biswas is a scholar working on Toxicology, Pharmacology and Immunology. According to data from OpenAlex, Pipasha Biswas has authored 15 papers receiving a total of 528 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Toxicology, 5 papers in Pharmacology and 4 papers in Immunology. Recurrent topics in Pipasha Biswas's work include Pharmacovigilance and Adverse Drug Reactions (8 papers), Drug-Induced Adverse Reactions (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Pipasha Biswas is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (8 papers), Drug-Induced Adverse Reactions (4 papers) and Biosimilars and Bioanalytical Methods (3 papers). Pipasha Biswas collaborates with scholars based in United Kingdom, Poland and Switzerland. Pipasha Biswas's co-authors include Ronald D. Mann, Saad Shakir, Lynda V. Wilton, Shayne N. Freemantle, Richard M. Martin, Gillian Pearce, L. V. Wilton, Lynda Wilton, G. L. Pearce and Samantha K. Powers and has published in prestigious journals such as Cell Reports, Osteoporosis International and British Journal of Clinical Pharmacology.

In The Last Decade

Pipasha Biswas

15 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Pipasha Biswas United Kingdom	10	137	98	89	73	63	15	528
Emmanuelle Bondon‐Guitton France	17	178 1.3×	148 1.5×	122 1.4×	56 0.8×	98 1.6×	44	834
Katrin Farker Germany	10	97 0.7×	104 1.1×	96 1.1×	27 0.4×	23 0.4×	31	483
L. V. Wilton United Kingdom	15	129 0.9×	161 1.6×	226 2.5×	138 1.9×	153 2.4×	22	816
Yamato Kato Japan	13	136 1.0×	105 1.1×	44 0.5×	30 0.4×	41 0.7×	25	423
Ryogo Umetsu Japan	13	168 1.2×	110 1.1×	55 0.6×	23 0.3×	44 0.7×	21	467
C. Noblet France	8	280 2.0×	148 1.5×	149 1.7×	42 0.6×	32 0.5×	17	633
G. L. Pearce United Kingdom	18	56 0.4×	183 1.9×	101 1.1×	152 2.1×	115 1.8×	28	888
Natsumi Ueda Japan	13	150 1.1×	111 1.1×	40 0.4×	32 0.4×	43 0.7×	24	468
Corine Ekhart Netherlands	14	84 0.6×	89 0.9×	116 1.3×	104 1.4×	34 0.5×	35	763
Michele Tari Italy	13	37 0.3×	53 0.5×	78 0.9×	34 0.5×	54 0.9×	26	615

Countries citing papers authored by Pipasha Biswas

Since Specialization

Citations

This map shows the geographic impact of Pipasha Biswas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pipasha Biswas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pipasha Biswas more than expected).

Fields of papers citing papers by Pipasha Biswas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pipasha Biswas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pipasha Biswas. The network helps show where Pipasha Biswas may publish in the future.

Co-authorship network of co-authors of Pipasha Biswas

This figure shows the co-authorship network connecting the top 25 collaborators of Pipasha Biswas. A scholar is included among the top collaborators of Pipasha Biswas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pipasha Biswas. Pipasha Biswas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Dutta, Debdeep, Samantha K. Powers, Paweł Lisowski, et al.. (2022). Mechanisms of IRF2BPL-related disorders and identification of a potential therapeutic strategy. Cell Reports. 41(10). 111751–111751. 8 indexed citations

Biswas, Pipasha. (2013). Pharmacovigilance in Asia. Journal of Pharmacology and Pharmacotherapeutics. 4(1_suppl). S7–S19. 54 indexed citations

Biswas, Pipasha. (2008). Pharmacovigilance: Safety matters….. PubMed. 40(Suppl 1). S1–2. 3 indexed citations

Biswas, Pipasha. (2008). Pharmacovigilance: Safety matters.. Indian Journal of Pharmacology. 40(7). 1–1. 2 indexed citations

Biswas, Pipasha, et al.. (2007). Setting standards for proactive pharmacovigilance in India: The way forward. Indian Journal of Pharmacology. 39(3). 124–124. 33 indexed citations

Biswas, Pipasha, Lynda V. Wilton, & Saad Shakir. (2003). The pharmacovigilance of mirtazapine: results of a prescription event monitoring study on 13 554 patients in England. Journal of Psychopharmacology. 17(1). 121–126. 37 indexed citations

Biswas, Pipasha, Lynda V. Wilton, & Saad Shakir. (2003). Pharmacovigilance study of alendronate in England. Osteoporosis International. 14(6). 507–514. 62 indexed citations

Biswas, Pipasha, et al.. (2002). The safety of valsartan: results of a postmarketing surveillance study on 12 881 patients in England. Journal of Human Hypertension. 16(11). 795–803. 40 indexed citations

Biswas, Pipasha, L. V. Wilton, & Saad Shakir. (2001). Montelukast and improvement of eczema: observations from a prescription event monitoring study in England. International Journal of Clinical Pharmacology and Therapeutics. 39(12). 529–533. 6 indexed citations

10.

Biswas, Pipasha, Lynda V. Wilton, & Saad Shakir. (2001). Troglitazone and Liver Function Abnormalities. Drug Safety. 24(2). 149–154. 11 indexed citations

11.

Biswas, Pipasha, Lynda V. Wilton, Gillian Pearce, Shayne N. Freemantle, & Saad Shakir. (2001). The pharmacovigilance of olanzapine: results of a post-marketing surveillance study on 8858 patients in England. Journal of Psychopharmacology. 15(4). 265–271. 48 indexed citations

12.

Biswas, Pipasha, Lynda Wilton, G. L. Pearce, et al.. (2001). Pharmacosurveillance and safety of the leukotriene receptor antagonist (LTRA), montelukast. 1(3). 300–304. 5 indexed citations

13.

Martin, Richard M., Pipasha Biswas, & Ronald D. Mann. (2000). The incidence of adverse events and risk factors for upper gastrointestinal disorders associated with meloxicam use amongst 19 087 patients in general practice in England: cohort study. British Journal of Clinical Pharmacology. 50(1). 35–42. 45 indexed citations

14.

Mann, Ronald D., Pipasha Biswas, Shayne N. Freemantle, G. L. Pearce, & Lynda Wilton. (2000). The pharmacovigilance of tamsulosin: event data on 12 484 patients. British Journal of Urology. 85(4). 446–450. 24 indexed citations

15.

Martin, Richard M., Pipasha Biswas, Shayne N. Freemantle, Gillian Pearce, & Ronald D. Mann. (1998). Age and sex distribution of suspected adverse drug reactions to newly marketed drugs in general practice in England: analysis of 48 cohort studies. British Journal of Clinical Pharmacology. 46(5). 505–511. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact